These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 2835743

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Seroconversion rates to combined measles-mumps-rubella-varicella vaccine of children with upper respiratory tract infection.
    Dennehy PH, Saracen CL, Peter G.
    Pediatrics; 1994 Oct; 94(4 Pt 1):514-6. PubMed ID: 7936862
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Evaluation of a combined measles-mumps-rubella-chickenpox vaccine.
    Just M, Berger R, Just V.
    Dev Biol Stand; 1986 Oct; 65():85-8. PubMed ID: 3030863
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N, Kidokoro M, Suzuki K, Morita M.
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Interference between strains in live virus vaccines. II: Combined vaccination with varicella and measles-mumps-rubella vaccine.
    Berger R, Just M.
    J Biol Stand; 1988 Oct; 16(4):275-9. PubMed ID: 2848843
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of live attenuated varicella vaccine (Oka-RIT strain) and combined varicella and MMR vaccination in 13-17-month-old children.
    Vesikari T, Ohrling A, Baer M, Delem A, Bogaerts H, André FE.
    Acta Paediatr Scand; 1991 Nov; 80(11):1051-7. PubMed ID: 1661057
    [Abstract] [Full Text] [Related]

  • 12. [Clinico-immunologic evaluation of a trivalent vaccine against measles, rubella and mumps].
    Schettini F, Manzionna MM, De Mattia D, Amendola F, Di Bitonto G.
    Minerva Pediatr; 1989 Mar; 41(3):117-22. PubMed ID: 2747598
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a combined vaccine against measles-mumps-rubella produced on human diploid cells.
    Just M, Berger R, Glück R, Wegmann A.
    Dev Biol Stand; 1986 Mar; 65():25-7. PubMed ID: 3549399
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of mumps antibodies after measles-mumps-rubella (MMR) vaccines.
    Ozaki K, Kuno-Sakai H, Kimura M.
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):305-11. PubMed ID: 3508655
    [Abstract] [Full Text] [Related]

  • 15. [Combined or coadministred Measles, Mumps, Rubella and Varicella Vaccines? That is the question!].
    Laudati F, Zaratti L, Franco E.
    Ig Sanita Pubbl; 2012 Dec; 68(2):313-21. PubMed ID: 23064094
    [Abstract] [Full Text] [Related]

  • 16. Protection of mumps in children with various underlying diseases: application of a live attenuated mumps and trivalent measles-rubella-mumps (MRM) vaccines in these children.
    Kanesaki T, Baba K, Tsuda N, Yabuuchi H, Yamanishi K, Takahashi M.
    Biken J; 1986 Dec; 29(3-4):63-71. PubMed ID: 3304276
    [Abstract] [Full Text] [Related]

  • 17. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE, Peetermans J.
    Dev Biol Stand; 1986 Dec; 65():101-7. PubMed ID: 3556770
    [Abstract] [Full Text] [Related]

  • 18. A randomized comparative trial in order to assess the reactogenicity and immunogenicity of a new measles mumps rubella (MMR) vaccine when given as a first dose at 12-24 months of age.
    Gatchalian S, Cordero-Yap L, Lu-Fong M, Soriano R, Ludan A, Chitour K, Bock HL.
    Southeast Asian J Trop Med Public Health; 1999 Sep; 30(3):511-7. PubMed ID: 10774661
    [Abstract] [Full Text] [Related]

  • 19. Safety and immunogenicity of concurrent administration of measles-mumps-rubella-varicella vaccine and PedvaxHIB vaccines in healthy children twelve to eighteen months old. The MMRV Study Group.
    Reuman PD, Sawyer MH, Kuter BJ, Matthews H.
    Pediatr Infect Dis J; 1997 Jul; 16(7):662-7. PubMed ID: 9239770
    [Abstract] [Full Text] [Related]

  • 20. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.